Clinical Trials Directory

Trials / Completed

CompletedNCT05123521

Drug Abuse Among Elective Surgeries: an Observational Study.

Incidence of Drug Abuse at the Cairo University Teaching Hospital Among Patients Who Underwent Elective Surgeries

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers

Summary

Drug abusers and addicts form a challenge to the anesthetist because of the added potential risks involved in the administration of anesthesia to this subset of patients, including potential unforeseen drug-drug interactions. In this study, we aimed at screening all patients scheduled for elective orthopedic or general surgeries at the Cairo University Teaching Hospital during a set period of time for the most commonly abused drugs in Egypt.

Detailed description

All patients included in the study consented to take part in this study. Each patient was asked to answer a questionnaire and submit a urine sample in order to be screened for the most commonly abused drugs in Egypt (hashish, tramadol, benzodiazepine, and morphine). Patients were then followed up both intra and post-operatively. Values of patient vital signs, Richmond Agitation-Sedation Scale (RASS) scores as well as clinical recovery scores (CRS) were all diligently recorded and analyzed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTurine analysisUrine was then tested for evidence of substance abuse using the multi-drug screen panel dip steak ABONtm (Abon Biopharm (Hangzhou) CO., Ltd) which is a lateral flow chromatographic immunoassay . It allowed for qualitative detection of multiple drugs in a single run. This kit was chosen for its ability to detect the most commonly abused substances in Egypt, namely: opioids, benzodiazepines, hashish, and tramadol. A single coloured line at region C for of a specific drug indicated a positive result, whilst two coloured lines at both regions C and T indicated a negative result. The absence of coloured lines was an indication of the invalidity of the particular kit, and the kit was discarded.

Timeline

Start date
2018-08-01
Primary completion
2019-01-28
Completion
2019-02-28
First posted
2021-11-17
Last updated
2021-11-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05123521. Inclusion in this directory is not an endorsement.